Breastcancer.org Podcast

338 Afleveringen

1. Mental Health Benefits of Pets

   Gepubliceerd: 19-8-2022
2. How Therapy Can Help People Affected by Breast Cancer

   Gepubliceerd: 5-8-2022
3. Fezolinetant: A Non-Hormonal Treatment for Hot Flashes

   Gepubliceerd: 22-7-2022
4. Enhertu for HER2-Low Breast Cancer

   Gepubliceerd: 8-7-2022
5. Loosening COVID-19 Restrictions and Immunocompromised People: Do You Feel Left Behind?

   Gepubliceerd: 24-6-2022
6. Genetic and Genomic Tests: What’s the Difference?

   Gepubliceerd: 2-6-2022
7. Just Ask: Increasing Diversity in Clinical Trials

   Gepubliceerd: 27-5-2022
8. Dating and Breast Cancer

   Gepubliceerd: 29-4-2022
9. Adolescent and Young Adult Breast Cancer

   Gepubliceerd: 28-3-2022
10. Top Research Presented at the 2021 San Antonio Breast Cancer Symposium

    Gepubliceerd: 21-12-2021
11. Aromatase Inhibitors versus Tamoxifen for Pre-Menopausal Women Diagnosed With Early-Stage, Hormone Receptor-Positive Disease

    Gepubliceerd: 13-12-2021
12. Experimental Elacestrant: A Standard of Care for Pre-Treated, Metastatic, Hormone Receptor-Positive, HER2-Negative Breast Cancer?

    Gepubliceerd: 11-12-2021
13. Alcohol and Breast Cancer Risk

    Gepubliceerd: 5-11-2021
14. Breast Cancer Research at ESMO 2021

    Gepubliceerd: 21-10-2021
15. Kisqali Plus Femara Seems Best Option for Advanced-Stage Hormone-Receptor-Positive HER2-Negative Breast Cancer

    Gepubliceerd: 1-10-2021
16. Keytruda Added to Chemotherapy Improves Overall Survival for Metastatic PD-L1-Positive, Triple-Negative Breast Cancer

    Gepubliceerd: 24-9-2021
17. The Importance of Diversity in Breast Cancer Clinical Trials

    Gepubliceerd: 15-9-2021
18. Tattoo Ink Showing Up on Mammograms

    Gepubliceerd: 20-8-2021
19. Immunotherapy Keytruda for Early-Stage Triple-Negative Breast Cancer: Better pCR and Lower Recurrence Rates: ESMO 2019 Coverage

    Gepubliceerd: 27-7-2021
20. Reconstruction Options After Lumpectomy

    Gepubliceerd: 16-7-2021